| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.13 | 0.5 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.5 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |